All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Ocular Therapeutix, Inc. revenue reports

Ocular Therapeutix, Inc. financial reports, Ocular Therapeutix, Inc. annual revenue in 2024. When does Ocular Therapeutix, Inc. report revenue?
Add to widgets
Added to widgets

Ocular Therapeutix, Inc. total revenue, net income and dynamics of changes in US dollar today

Ocular Therapeutix, Inc. revenue for the past few reporting periods. Ocular Therapeutix, Inc. net income is now 3 121 000 $. The dynamics of Ocular Therapeutix, Inc. net income rose by 88 733 000 $. The assessment of the dynamics of Ocular Therapeutix, Inc. net income was made in comparison with the previous report. The financial report on the chart of Ocular Therapeutix, Inc. allows you to clearly see the dynamics of fixed assets. The value of the "total revenue of Ocular Therapeutix, Inc." on the chart is marked in yellow. A graph of the value of all Ocular Therapeutix, Inc. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 7 342 000 $ +1 392.280 % ↑ 3 121 000 $ -
31/12/2020 7 349 000 $ +1 358.130 % ↑ -85 612 000 $ -
30/09/2020 5 876 000 $ +608.81 % ↑ -11 944 000 $ -
30/06/2020 1 569 000 $ +141.38 % ↑ -36 568 000 $ -
30/09/2019 829 000 $ - -18 778 000 $ -
30/06/2019 650 000 $ - -24 453 000 $ -
31/03/2019 492 000 $ - -17 124 000 $ -
31/12/2018 504 000 $ - -17 399 000 $ -
30/09/2018 498 000 $ - -15 010 000 $ -
30/06/2018 648 000 $ - -13 804 000 $ -
31/03/2018 340 000 $ - -13 765 000 $ -
31/12/2017 487 000 $ - -13 102 000 $ -
30/09/2017 523 000 $ - -15 567 000 $ -
30/06/2017 438 000 $ - -18 694 000 $ -
Show:
to

Ocular Therapeutix, Inc. financial report charts

Dates of Ocular Therapeutix, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Ocular Therapeutix, Inc. is available online for such a date - 31/03/2021. Gross profit Ocular Therapeutix, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Ocular Therapeutix, Inc. is -4 477 000 $

Ocular Therapeutix, Inc. quarterly report dates

Cost of revenue Ocular Therapeutix, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Ocular Therapeutix, Inc. is 11 819 000 $ Total revenue Ocular Therapeutix, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Ocular Therapeutix, Inc. is 7 342 000 $ Operating income Ocular Therapeutix, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Ocular Therapeutix, Inc. is -20 228 000 $

Net income Ocular Therapeutix, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Ocular Therapeutix, Inc. is 3 121 000 $ Current assets Ocular Therapeutix, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Ocular Therapeutix, Inc. is 228 132 000 $ Total assets Ocular Therapeutix, Inc. refers to the total amount of assets owned by a person or entity. Total assets Ocular Therapeutix, Inc. is 243 040 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-4 477 000 $ -955 000 $ -1 525 000 $ -6 586 000 $ -10 212 000 $ -9 316 000 $ -10 953 000 $ -9 871 000 $ -9 302 000 $ -8 250 000 $ 260 000 $ 374 000 $ 398 000 $ 334 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
11 819 000 $ 8 304 000 $ 7 401 000 $ 8 155 000 $ 11 041 000 $ 9 966 000 $ 11 445 000 $ 10 375 000 $ 9 800 000 $ 8 898 000 $ 80 000 $ 113 000 $ 125 000 $ 104 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 342 000 $ 7 349 000 $ 5 876 000 $ 1 569 000 $ 829 000 $ 650 000 $ 492 000 $ 504 000 $ 498 000 $ 648 000 $ 340 000 $ 487 000 $ 523 000 $ 438 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 829 000 $ 650 000 $ 492 000 $ 504 000 $ 498 000 $ 648 000 $ 340 000 $ 487 000 $ 523 000 $ 438 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-20 228 000 $ -14 343 000 $ -14 006 000 $ -17 884 000 $ -23 144 000 $ -21 599 000 $ -19 658 000 $ -17 283 000 $ -14 816 000 $ -13 564 000 $ -13 455 000 $ -12 716 000 $ -15 196 000 $ -18 339 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
3 121 000 $ -85 612 000 $ -11 944 000 $ -36 568 000 $ -18 778 000 $ -24 453 000 $ -17 124 000 $ -17 399 000 $ -15 010 000 $ -13 804 000 $ -13 765 000 $ -13 102 000 $ -15 567 000 $ -18 694 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - 11 317 000 $ 11 317 000 $ 11 317 000 $ 11 317 000 $ 8 227 000 $ 7 908 000 $ 8 126 000 $ 8 117 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
27 570 000 $ 21 692 000 $ 19 882 000 $ 19 453 000 $ 23 973 000 $ 22 249 000 $ 20 150 000 $ 17 787 000 $ 15 314 000 $ 14 212 000 $ 13 715 000 $ 13 090 000 $ 15 594 000 $ 18 673 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
228 132 000 $ 246 160 000 $ 81 903 000 $ 90 293 000 $ 69 636 000 $ 65 436 000 $ 79 172 000 $ 56 193 000 $ 58 274 000 $ 58 472 000 $ 64 476 000 $ 43 339 000 $ 52 453 000 $ 68 328 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
243 040 000 $ 261 863 000 $ 98 219 000 $ 107 260 000 $ 88 710 000 $ 89 742 000 $ 101 490 000 $ 73 043 000 $ 70 270 000 $ 70 459 000 $ 76 685 000 $ 55 431 000 $ 64 399 000 $ 79 675 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
209 378 000 $ 228 057 000 $ 70 642 000 $ 84 294 000 $ 65 414 000 $ 61 765 000 $ 76 251 000 $ 54 062 000 $ 56 861 000 $ 56 834 000 $ 64 525 000 $ 41 538 000 $ 51 165 000 $ 63 049 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 11 005 000 $ 10 127 000 $ 8 614 000 $ 9 159 000 $ 13 406 000 $ 11 899 000 $ 6 071 000 $ 5 545 000 $ 3 993 000 $ 2 444 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - 62 911 000 $ 41 538 000 $ 51 165 000 $ 66 049 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 77 409 000 $ 81 484 000 $ 75 842 000 $ 37 168 000 $ 24 753 000 $ 24 730 000 $ 17 085 000 $ 18 016 000 $ 17 917 000 $ 17 818 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 87.26 % 90.80 % 74.73 % 50.89 % 35.23 % 35.10 % 22.28 % 32.50 % 27.82 % 22.36 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
83 408 000 $ 76 095 000 $ -4 126 000 $ 5 344 000 $ 11 301 000 $ 8 258 000 $ 25 648 000 $ 35 875 000 $ 45 517 000 $ 45 729 000 $ 49 184 000 $ 26 147 000 $ 35 922 000 $ 48 025 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -19 544 000 $ -19 181 000 $ -19 386 000 $ -13 648 000 $ -10 873 000 $ -12 233 000 $ -12 473 000 $ -10 383 000 $ -14 382 000 $ -11 131 000 $

Last revenue report of Ocular Therapeutix, Inc. was 31/03/2021. According to last financial report total revenue in Ocular Therapeutix, Inc. was 7 342 000 US dollar and changed by +1 392.280% since last year. Net income in Ocular Therapeutix, Inc. was 3 121 000 $ in last quartal, net income changes to 0%.

Current cash Ocular Therapeutix, Inc. - the sum of all of the cash a company has on the date of report. Current cash Ocular Therapeutix, Inc. is 209 378 000 $

Ocular Therapeutix, Inc. stocks data

Ocular Therapeutix, Inc. financials